Biotech drugmaker Tesaro Inc. is expecting an FDA decision on a similar drug next year. "This approval gives Clovis the chance to build a market in ...
News
- US FDA clears ovarian cancer drug for hard-to-treat disease
- Memorial-area Girl Scouts receive national recognition
Coulter aspires to pursue a major in biomedical science when she graduates in the spring. DeSanctis, a senior at St. Agnes Academy, earned the ...
- News review of 2 biotech stocks: Incyte Corporation (NASDAQ:INCY), Corcept Therapeutics ...
The data were presented at the 2016 San Antonio Breast Cancer Symposium. This open-label trial was designed to investigate whether the addition of ...
- San Antonio executives partner for new Austin bank
J. Bruce Bugg Jr., chairman of The Bank of San Antonio, will serve as ... biotech entrepreneur and investor; and Brent Given, Bank of San Antonio's ...
- 2 Biotech Stocks News And Price Trends: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE ...
2 Biotech Stocks News And Price Trends: Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE), Radius Health, Inc. (NASDAQ:RDUS) ...